Product Information
MOXIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $1.5963 per ML under NDC 00781713593. Its NADAC has been published 468 times since Oct 18, 2017.
FDA first approved this application on Apr 15, 2003. Its Orange Book therapeutic-equivalence code is AT1.
Strength
5 mg/mL
Manufacturer
Sandoz Inc.NDC
00781713593
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021598FDA Approved
4/15/2003
TE Code
AT1
On Market Since
5/7/2003
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROPS has been published 468 times since Oct 18, 2017, and over the history we have for it it has declined 85.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5963 per ML |
|---|---|
| All-time high | $10.8061 (Dec 13, 2017) |
| All-time low | $1.5386 (Aug 19, 2026) |
| 52-week high | $1.8460 |
| 52-week low | $1.5386 |
| Median price | $4.2975 |
| Average price | $4.7219 |
| Largest weekly change | +41.1% (Nov 23, 2022) |
| Weeks tracked | 468 |
| Tracking since | Oct 18, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
moxifloxacin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROPS, manufactured by Sandoz Inc., is $1.5963 per ML (NDC 00781713593), effective Sep 30, 2026.
How has the price of MOXIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has declined 85.1%. It has been tracked across 468 weekly CMS publications since Oct 18, 2017.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROPS?
Since Oct 18, 2017, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has ranged from a low of $1.5386 (Aug 19, 2026) to a high of $10.8061 (Dec 13, 2017), with a median of $4.2975 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MOXIFLOXACIN 0.5% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures MOXIFLOXACIN 0.5% EYE DROPS?
MOXIFLOXACIN 0.5% EYE DROPS (NDC 00781713593) is labeled by Sandoz Inc., and CMS classifies it as a generic product.